Last reviewed · How we verify

SD Vaccine

Insight Therapeutics, LLC · FDA-approved active Biologic ✓ Verified May 2026 Quality 5/100

SD Vaccine is a Biologic drug developed by Insight Therapeutics, LLC. It is currently FDA-approved. Also known as: Fluzone.

The SD Vaccine is a small molecule intervention that has been studied in various clinical trials for conditions such as influenza, HIV, cancer, immunization, infection, and transplantation infection. It has been tested in the form of high-dose and standard-dose trivalent influenza vaccines, including Fluzone High Dose Vaccine, in adults aged 50-64 years.

At a glance

Generic nameSD Vaccine
Also known asFluzone
SponsorInsight Therapeutics, LLC
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about SD Vaccine

What is SD Vaccine?

SD Vaccine is a Biologic drug developed by Insight Therapeutics, LLC.

Who makes SD Vaccine?

SD Vaccine is developed and marketed by Insight Therapeutics, LLC (see full Insight Therapeutics, LLC pipeline at /company/insight-therapeutics-llc).

Is SD Vaccine also known as anything else?

SD Vaccine is also known as Fluzone.

What development phase is SD Vaccine in?

SD Vaccine is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing